BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16702375)

  • 1. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
    Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
    Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
    Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
    Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
    Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer.
    Beaber EF; Holt VL; Malone KE; Porter PL; Daling JR; Li CI
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3427-34. PubMed ID: 19064558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for ductal and lobular breast cancer: results from the nurses' health study.
    Kotsopoulos J; Chen WY; Gates MA; Tworoger SS; Hankinson SE; Rosner BA
    Breast Cancer Res; 2010; 12(6):R106. PubMed ID: 21143857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
    Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
    Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
    Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
    Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
    Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
    Li CI; Weiss NS; Stanford JL; Daling JR
    Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between menopausal symptoms and risk of postmenopausal breast cancer.
    Huang Y; Malone KE; Cushing-Haugen KL; Daling JR; Li CI
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):379-88. PubMed ID: 21212063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Daling JR
    Int J Cancer; 2003 Nov; 107(4):647-51. PubMed ID: 14520705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.
    Kjartansdottir OJ; Sigurdardottir LG; Olafsdottir EJ; Jonasson JG; Ursin G; Tryggvadottir L
    Breast Cancer Res Treat; 2017 Jun; 163(2):363-373. PubMed ID: 28281022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype.
    Calle EE; Feigelson HS; Hildebrand JS; Teras LR; Thun MJ; Rodriguez C
    Cancer; 2009 Mar; 115(5):936-45. PubMed ID: 19156895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.